vimarsana.com

Page 225 - மருத்துவ ரீதியாக ஒருங்கிணைந்த வலைப்பின்னல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Laparoscopy and Endoscopy Devices Market Size Worth USD 28 30 Billion by 2027 | Growing Demand for Minimally Invasive Surgery is One of the Significant Factors Influencing the Industry Growth, says Emergen Research

Laparoscopy and Endoscopy Devices Market Size Worth USD 28.30 Billion by 2027 | Growing Demand for Minimally Invasive Surgery is One of the Significant Factors Influencing the Industry Growth, says Emergen Research Key participants in Laparoscopy and Endoscopy Devices Marke include Stryker Corporation, Fujifilm, Smith & Nephew PLC, Cook Medical, Boston Scientific, B. Braun Melsungen, Olympus, Medtronic, Karl Storz, and Hoya Corporation, among others. February 10, 2021 04:57 ET | Source: Emergen Research Emergen Research Surrey, CANADA Vancouver, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) The global laparoscopy and endoscopy devices market is projected to be worth USD 28.30 Billion by 2027growing at a CAGR of 4.3%, according to a current analysis by Emergen Research. The laparoscopy and endoscopy devices market is observing high demand attributed to the increasing demand for minimally invasive surgery. Min

Taxing time: How the pandemic will affect filing your taxes

COVID-19 Vaccine Appointments to Open at 593 Florida Publix Pharmacies

SpyBiotech raises $32 5M in Series A funding and appoints Lutz B Giebel as Chairman to support its novel vaccine platform through accelerated clinical development

(1) SpyBiotech has raised $32.5M from leading investors to advance development of its novel plug and display vaccine platform technology Braavos Investment Advisers led the round, joined by new investor Oxford Investment Consultants; founding investors Oxford Sciences Innovation and GV also participated Lutz B. Giebel joins as Chairman, strengthening governance as company expands clinical development and builds operational resource OXFORD, United Kingdom, Feb. 10, 2021 (GLOBE NEWSWIRE) SpyBiotech, a British biotechnology company with a novel vaccine platform technology targeting infectious diseases, cancer and chronic diseases, today announces it has raised $32.5 million in Series A equity financing and appointed Lutz B. Giebel as Chairman.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.